Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
XREF LIMITED
ACN 122 404 666
NOTICE OF 2019 ANNUAL GENERAL MEETING
TIME:
11:00am
DATE:
29 November 2019
PLACE:
Xref Limited’s office
Suite 17, Level 3, 13 Hickson Road, Dawes Point, Sydney NSW
This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should
vote, they should seek advice from their professional advisers prior to voting.
Should you wish to discuss the matters in this Notice of Meeting please do not hesitate to contact the
Company Secretary on (02) 8244 3099.
CONTENTS PAGE
Business of the Meeting (setting out the proposed resolutions)
2
Explanatory Notes (explaining the proposed resolutions)
4
Glossary
12
Annexure 1 – Proportional Takeover Approval Provisions
13
Proxy Form
Enclosed
IMPORTANT INFORMATION
TIME AND PLACE OF MEETING
Notice is given that the Xref Limited 2019 Annual General Meeting (AGM or Meeting) will be held at 11:00am
(AEDT) on 29 November 2019 at:
Xref Limited’s office
Suite 17, Level 3, 13 Hickson Road, Dawes Point, Sydney NSW
YOUR VOTE IS IMPORTANT
The business of the Meeting affects your shareholding and your vote is important.
VOTING ELIGIBILITY
The Directors have determined, pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth), that
the persons eligible to vote at the Meeting are those who are registered Shareholders at 7:00pm (AEDT) on
27 November 2019.
VOTING IN PERSON
To vote in person, attend the Meeting at the time, date and place set out above.
VOTING BY PROXY
To vote by proxy, please complete and sign the enclosed Proxy Form, and return it by the time, and in accordance
with the instructions, set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, members are advised that:
•
each member has a right to appoint a proxy;
•
the proxy need not be a member of the Company; and
•
a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the
proportion or number of votes each proxy is appointed to exercise. If the member appoints two proxies,
and the appointment does not specify the proportion or number of the member’s votes, then, in
accordance with section 249X(3) of the Corporations Act, each proxy may exercise half of the votes.
1
BUSINESS OF THE MEETING
AGENDA
1.
TO CONSIDER THE FINANCIAL STATEMENTS AND REPORTS
To consider the Reports of the Directors and the Auditor, and the Financial Statements of the
Company for the year ended 30 June 2019.
Note: This item of business is for discussion purposes only and is not a Resolution. Shareholders will be
given a reasonable opportunity at the AGM to ask questions about, or make comments in relation to, each
of the reports during the consideration of this item.
2.
RESOLUTION 1 – TO APPROVE THE REMUNERATION REPORT
To consider and, if thought fit, to pass, with or without amendment, the following resolution as a nonbinding resolution:
“That, for the purpose of section 250R(2) of the Corporations Act and for all other purposes, approval is
given for the adoption of the Remuneration Report as contained in the Company’s Annual Financial Report
for the financial year ended 30 June 2019.”
Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.
Voting Exclusion Statement: A vote on this Resolution must not be cast (in any capacity) by or on behalf
of either of the following persons:
a)
a member of the Key Management Personnel, details of whose remuneration are included in the
Remuneration Report; or
b)
a Closely Related Party of such a member.
However, a person (the voter) described above may cast a vote on this Resolution as a proxy if the vote is
not cast on behalf of a person described above and either:
a)
b)
3.
the voter is appointed as a proxy by writing that specifies the way the proxy is to vote on this
Resolution; or
the voter is the Chair and the appointment of the Chair as proxy:
(i)
does not specify the way the proxy is to vote on this Resolution; and
(ii)
expressly authorises the Chair to exercise the proxy even though this Resolution is connected
directly or indirectly with the remuneration of a member of the Key Management Personnel.
RESOLUTION 2 – TO RE-ELECT A DIRECTOR – MR NIGEL HEAP
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
ordinary resolution:
“That Mr Nigel Heap, a Director, retires by rotation, and being eligible, is re-elected as a Director.”
4.
RESOLUTION 3 – TO RE-ELECT A DIRECTOR – MR BRAD ROSSER
To consider and, if thought fit, to pass, with or without amendment, the following resolution as an
ordinary resolution:
“That Mr Brad Rosser, a Director, retires by rotation, and being eligible, is re-elected as a Director.”
5.
RESOLUTION 4 – TO APPROVE A 10% PLACEMENT FACILITY
To consider and, if thought fit, to pass, the following resolution as a special resolution:
“That, pursuant to, and in accordance with, ASX Listing Rule 7.1A and for all other purposes, Shareholders
approve the issue of Equity Securities of up to 10% of the issued capital of the Company (at the time of the
issue) calculated in accordance with the formula prescribed in ASX Listing Rule 7.1A.2, and on the terms
and conditions set out in the Explanatory Notes.”
2
Voting Exclusion Statement: The Company will disregard any votes cast in favour on Resolution 4 by any
person (and any associates of such a person) who may participate in the 10% Placement Facility and any
person (and any associates of such a person) who might obtain a benefit, except a benefit solely in the
capacity of a holder of ordinary shares, if Resolution 4 is passed. However, the Company need not
disregard any vote by any such persons if it is cast by any of them as proxy for a person who is entitled to
vote, in accordance with the directions on the Proxy Form, or if it is cast by the person who is chairing the
AGM as proxy for a person who is entitled to vote in accordance with a direction on the Proxy Form to
vote as the proxy decides.
6.
RESOLUTION 5 – TO RE-INSERT PROPORTIONAL TAKEOVER PROVISIONS IN THE CONSTITUTION
To consider and, if thought fit, to pass, the following resolution as a special resolution:
“That the proportional takeover provisions in clause 22 of the Company’s Constitution, as included in this
Notice of Meeting as Annexure A, be re-inserted into the Constitution for a period of three years
commencing on the day this Resolution is passed.”
Dated 25 October 2019
By order of the Board
Robert J Waring
Company Secretary
3
EXPLANATORY NOTES
These Explanatory Notes have been prepared to provide information that the Directors believe to be material to
Shareholders in deciding whether or not to pass the Resolutions that are the subject of the business of the AGM.
1.
TO CONSIDER THE FINANCIAL STATEMENTS AND REPORTS
In accordance with the Constitution, the business of the Meeting will include the receipt and consideration
of the Annual Financial Report of the Company for the financial year ended 30 June 2019 together with
the Declaration of the Directors, the Directors’ Report, the Remuneration Report and the Auditor’s Report.
Xref will not provide a hard copy of the Company’s Annual Report to Shareholders unless specifically
requested to do so. Xref’s Annual Report is available in the Investor Centre section of its website at
https://xref.com/en/investor-centre.
2.
RESOLUTION 1 – TO APPROVE THE REMUNERATION REPORT
General
The Corporations Act requires that, at a listed company’s annual general meeting, a resolution that the
remuneration report be adopted must be put to the shareholders. However, such a resolution is advisory
only and does not bind the company or the directors of the company.
The remuneration report sets out the company’s remuneration arrangements for the directors and senior
management of the company. The remuneration report is part of the directors’ report contained in the
annual financial report of the company for a financial year.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask questions about
or make comments on the remuneration report at the annual general meeting.
Voting Consequences
A company is required to put to its shareholders a resolution proposing the calling of another meeting of
shareholders to consider the appointment of directors of the company (Spill Resolution) if, at consecutive
annual general meetings, at least 25% of the votes cast on a remuneration report resolution are voted
against the adoption of the remuneration report and, at the first of those annual general meetings, a Spill
Resolution was not put to vote. If required, the Spill Resolution must be put to vote at the second of those
annual general meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must convene a
shareholder meeting (Spill Meeting) within 90 days of the second annual general meeting.
All of the directors of the company who were in office when the directors' report (as included in the
company’s annual financial report for the most recent financial year) was approved, other than the
managing director of the company, will cease to hold office immediately before the end of the Spill
Meeting, but may stand for re-election at the Spill Meeting.
Following the Spill Meeting those persons whose election or re-election as directors of the company is
approved will be the directors of the company.
Previous Voting Results
At Xref’s previous annual general meeting the votes cast against the remuneration report considered at
that annual general meeting were less than 25%. Accordingly, the Spill Resolution is not relevant for this
Annual General Meeting.
4
3.
RESOLUTIONS 2 AND 3 – TO RE-ELECT DIRECTORS
General
The Constitution sets out the requirements for determining which Directors are to retire by rotation at an
annual general meeting.
Clause 10.2(b) of the Constitution provides that if the ASX Listing Rules require an election of Directors to
be held at an annual general meeting, the Director to retire is:
a)
the Director who has held office as Director for the longest period of time since his or her last
election or appointment to that office; or
b)
if two or more Directors have held office for the same period of time, the Director determined by
lot, unless those Directors agree otherwise.
The Managing Director is not subject to the requirement to retire pursuant to clause 10.2 of the Constitution.
Qualifications and Other Material Directorships
Nigel Heap is the UK and Ireland Managing Director, and Chairman of the Asia Pacific business, of Hays plc,
the leading global professional recruitment group, and a member of the group's management board. He
joined Hays in 1988 and over the last 20 years has successfully led the growth of the Asia-Pacific business.
Mr Heap has completed INSEAD's Advanced Management Program and holds a Bachelor of Laws from
Manchester University.
Brad Rosser is a business builder and entrepreneur who worked for McKinsey and Co from 1992 to 1995
before working directly for Richard Branson as Director of Corporate Development for Virgin from 1995
to 1999, helping to identify and implement start-up businesses. He holds an MBA from Cornell
University's Johnson Graduate School of Management and a Bachelor of Commerce (Honours) from the
University of Western Australia.
Independence
If re-elected, the Board continues to consider Messrs Heap and Rosser to be independent Directors.
Directors’ Recommendation
The Board (except Mr Heap) supports the re-election of Mr Heap and recommends that Shareholders vote
in favour of Resolution 2.
The Board (except Mr Rosser) supports the re-election of Mr Rosser and recommends that Shareholders
vote in favour of Resolution 3.
4.
RESOLUTION 4 – TO APPROVE A 10% PLACEMENT FACILITY
Resolution 4 seeks Shareholder approval for a 10% placement facility. ASX Listing Rule 7.1A enables an
eligible entity to issue Equity Securities of up to 10% of its issued ordinary share capital through placements
over a 12-month period after its annual general meeting (10% Placement Facility). The 10% Placement
Facility is in addition to the eligible entity’s 15% placement capacity under ASX Listing Rule 7.1. An eligible
entity, for the purpose of ASX Listing Rule 7.1A, is an entity that is not included in the S&P / ASX 300 Index
and has a market capitalisation of $300 million or less. Xref is an eligible entity. The Company is now seeking
Shareholder approval by way of a Special Resolution to have the ability to issue Equity Securities under the
10% Placement Facility. The exact number of Equity Securities that may be issued under the 10% Placement
Facility will be determined in accordance with the formula prescribed in ASX Listing Rule 7.1A.2 (refer to
section ‘Formula for Calculating 10% Placement Facility’ below).
Description of ASX Listing Rule 7.1A
Shareholder Approval
The ability to issue Equity Securities under the 10% Placement Facility is subject to Shareholder approval
by way of a Special Resolution at an annual general meeting.
5
Equity Securities
Any Equity Securities issued under the 10% Placement Facility must be in the same class as an existing
quoted class of Equity Securities in Xref. The Company, as at the date of this Notice of AGM, has on issue
the following classes of Equity Securities:
167,461,812 fully paid ordinary shares, quoted on ASX;
16,666,666 C Class Performance Rights, not quoted on ASX, with an expiry date of 20 January 2021;
5,400,000 options, not quoted on ASX, with an exercise price of $0.70, and an expiry date of
25 November 2021;
2,500,000 options, not quoted on ASX, with an exercise price of $0.70 and an expiry date of
25 November 2022;
906,870 options issued under the Employee Option Plan (EOP), not quoted on ASX, with an exercise
price of $0.585 and an expiry date of 3 July 2021;
194,331 options issued under the EOP, not quoted on ASX, with an exercise price of $0.66 and an
expiry date of 5 February 2022;
2,500,000 options issued under the EOP, not quoted on ASX, with an exercise price of $0.70 (with
1,000,000 options expiring if not exercised by 12 February 2021, with 750,000 options expiring if
not exercised by 12 February 2022, and with 750,000 options expiring if not exercised by 12
February 2023);
315,664 options issued under the EOP, not quoted on ASX, with an exercise price of $0.66 and an
expiry date of 1 August 2022;
2,500,000 options issued under the EOP, not quoted on ASX, with an exercise price of $0.70 and an
expiry date of 29 November 2022;
300,000 Options issued under the EOP, not quoted on ASX, with an exercise price of $0.70 and an
expiry date of 3 September 2021;
300,000 Options issued under the EOP, not quoted on ASX, with an exercise price of $0.70 and an
expiry date of 3 September 2022; and
300,000 Options issued under the EOP, not quoted on ASX, with an exercise price of $0.70 and an
expiry date of 3 September 2023.
Formula for Calculating 10% Placement Facility
ASX Listing Rule 7.1A.2 provides that eligible entities that have obtained shareholder approval at an
annual general meeting may issue, or agree to issue, during the 10% Placement Period (refer to section
‘10% Placement Period’ below), a number of Equity Securities calculated in accordance with the following
formula:
(A x D) – E
Where:
A
is the number of fully paid ordinary shares on issue 12 months before the date of issue or agreement:
plus the number of fully paid ordinary shares issued in the 12 months under an exception in
ASX Listing Rule 7.2;
plus the number of partly paid ordinary shares that became fully paid ordinary shares in the
12 months;
plus the number of fully paid ordinary shares issued in the 12 months with approval of
holders of ordinary shares under ASX Listing Rules 7.1 and 7.4;
less the number of fully paid ordinary shares cancelled in the 12 months.
(Note that A has the same meaning as in ASX Listing Rule 7.1 when calculating an entity’s 15% placement
capacity.)
D
is 10%
E
is the number of Equity Securities issued, or agreed to be issued, under ASX Listing Rule 7.1A.2 in
the 12 months before the date of the issue, or agreement to issue, that are not issued with the
approval of shareholders under ASX Listing Rules 7.1 or 7.4.
ASX Listing Rules 7.1 and 7.1A
The ability of an entity to issue Equity Securities under ASX Listing Rule 7.1A is in addition to the entity’s
15% placement capacity under ASX Listing Rule 7.1.
6
At the date of this Notice of AGM, Xref has on issue 167,461,812 fully paid ordinary shares and therefore
has a capacity to issue:
a)
b)
25,119,272 Equity Securities under ASX Listing Rule 7.1; and
subject to Shareholder approval being obtained under Resolution 4, 16,746,181 Equity Securities
under ASX Listing Rule 7.1A.
The actual number of Equity Securities that the Company will have the capacity to issue under ASX Listing Rule
7.1A will be calculated at the date of issue of the Equity Securities in accordance with the formula prescribed
in ASX Listing Rule 7.1A.2 (refer to section ‘Formula for Calculating 10% Placement Facility’ above).
Minimum Issue Price
The issue price of Equity Securities issued under ASX Listing Rule 7.1A must be not less than 75% of the
volume-weighted average price (VWAP) of Equity Securities in the same class calculated over the 15
Trading Days on which trades in that class were recorded immediately before:
a)
the date on which the price at which the Equity Securities are to be issued is agreed; or
b)
if the Equity Securities are not issued within five Trading Days of the date referred to in section
‘Minimum Issue Price’ (a) above, the date on which the Equity Securities are issued.
10% Placement Period
Shareholder approval of the 10% Placement Facility under ASX Listing Rule 7.1A is valid from the date of
the AGM at which the approval is obtained and expires on the earlier to occur of:
a)
b)
the date that is 12 months after the date of the AGM at which the approval is obtained; or
the date of the approval by Shareholders of a transaction under ASX Listing Rules 11.1.2
(a significant change to the nature or scale of activities) or 11.2 (disposal of main undertaking);
or such longer period if allowed by ASX (10% Placement Period).
ASX Listing Rule 7.1A
The effect of Resolution 4 will be to allow the Directors to issue the Equity Securities under ASX Listing
Rule 7.1A during the 10% Placement Period in addition to using Xref’s 15% placement capacity under ASX
Listing Rule 7.1. Resolution 4 is a Special Resolution and therefore requires approval of at least 75% of
the votes cast by Shareholders entitled to vote (in person, by proxy, by attorney or, in the case of a
corporate shareholder, by a corporate representative) on the Resolution.
Specific Information Required by ASX Listing Rule 7.3A
Pursuant to, and in accordance with, ASX Listing Rule 7.3A, information is provided in relation to the
approval of the 10% Placement Facility as follows to the extent that such information is not disclosed
elsewhere in these Explanatory Notes:
a)
The Equity Securities will be issued at an issue price of not less than 75% of the VWAP for the
Company’s Equity Securities in the same class over the 15 Trading Days on which trades in that
class were recorded immediately before:
(i)
the date on which the price at which the Equity Securities are to be issued is agreed; or
(ii)
if the Equity Securities are not issued within five Trading Days of the date in section ‘Specific
Information Required by ASX Listing Rule 7.3A’ (a)(i) above, the date on which the Equity
Securities are issued.
b)
There is a risk that:
(i)
the market price for Xref’s Equity Securities in the same class may be significantly lower on
the date of the issue of the Equity Securities than on the date of the Meeting; and
(ii)
the Equity Securities may be issued at a price that is at a discount to the market price for the
Company’s Equity Securities in the same class on the issue date, which may have an effect
on the amount of funds raised by the issue of the Equity Securities.
The table below shows the risk of voting dilution of existing Shareholders on the basis of the current
market price of Shares and the current number of Shares for variable ‘A’ calculated in accordance
with the formula in ASX Listing Rule 7.1A.2 as at the date of this Notice of AGM. The table also shows:
two examples where variable ‘A’ has increased, by 50% and 100%. Variable ‘A’ is based on
the number of ordinary shares Xref has on issue. The number of ordinary shares on issue
may increase as a result of issues of ordinary shares that do not require Shareholder approval
7
(for example, a pro rata entitlement issue) or future-specific placements under ASX Listing
Rule 7.1 that are approved at a future Shareholders’ meeting; and
two examples of where the issue price of Shares has decreased by 50% and increased by
100% as against the current market price.
Variable ‘A’ in ASX Listing
Rule 7.1A.2
Current Variable A:
167,461,812 Shares
50% increase in current
Variable A:
251,192,718 Shares
100% increase in current
Variable A:
334,923,624 Shares
Dilution
10% Voting
Dilution
Funds
Raised
10% Voting
Dilution
Funds
Raised
10% Voting
Dilution
Funds
Raised
$0.21
50% decrease in
Issue Price
$0.42
Issue Price
$0.84
100% increase
Issue Price
16,746,181 shares
16,746,181 shares
16,746,181 shares
$3,516,698
$7,033,396
$14,066,792
25,119,272 shares
25,119,272 shares
25,119,272 shares
$5,275,047
$10,550,094
$21,100,188
33,492,362 shares
33,492,362 shares
33,492,362 shares
$7,033,396
$14,066,792
$28,133,584
The table has been prepared on the following assumptions:
c)
d)
e)
f)
The Company issues the maximum number of Equity Securities available under the 10%
Placement Facility;
No current Options are exercised into Shares before the date of the issue of the Equity Securities;
The 10% voting dilution reflects the aggregate percentage dilution against the issued Share
capital at the time of issue. This is why the voting dilution is shown in each example as 10%;
The table does not show an example of dilution that may be caused to a particular
Shareholder by reason of a placement under the 10% Placement Facility, based on that
Shareholder’s holding at the date of the Meeting;
The table shows only the effect of the issue of Equity Securities under ASX Listing Rule 7.1A,
not under the 15% placement capacity under ASX Listing Rule 7.1 and no other issues of
Equity Securities;
The issue of Equity Securities under the 10% Placement Facility consists only of Shares; and
The issue price is $0.42, being the closing price of the Shares on ASX on 7 October 2019.
Xref will only issue and allot the Equity Securities during the 10% Placement Period. The approval
under Resolution 4 for the issue of the Equity Securities will cease to be valid in the event that
Shareholders approve a transaction under ASX Listing Rules 11.1.2 (a significant change to the
nature or scale of activities) or 11.2 (disposal of main undertaking).
The Company may seek to issue the Equity Securities for the following purposes:
(i)
non-cash consideration for the acquisition of new assets and investments. In such
circumstances Xref will provide a valuation of the non-cash consideration as referred to in
the Note to ASX Listing Rule 7.1A.3; or
(ii)
cash consideration. In such circumstances, the Company intends to use the funds raised
towards an acquisition of new assets or investments (including expenses associated with
such an acquisition), for continued development of the Xref business in Australia, the UK,
Scandinavia, Canada and in the USA, and for ongoing future working capital purposes.
The Company will comply with the disclosure obligations under ASX Listing Rules 7.1A.4 and 3.10.5A
upon issue of any Equity Securities.
Xref’s allocation policy is dependent on the prevailing market conditions at the time of any
proposed issue pursuant to the 10% Placement Facility. The identity of the allottees of Equity
Securities and the number of Equity Securities allotted to each allottee will be determined on a
case-by-case basis having regard to factors including, but not limited to, the following:
(i)
the methods of raising funds that are available to the Company, including, but not limited
to, a rights issue or other issue in which the existing security holders can participate;
(ii)
the effect of the issue of the Equity Securities on the control of Xref;
8
(iii)
(iv)
the financial situation and solvency of the Company; and
advice from corporate, financial and broking advisers (if applicable).
The allottees under the 10% Placement Facility have not been determined as at the date of this Notice
of AGM, but may include existing substantial Shareholders and / or new shareholders who are not
related parties or associates of a related party of Xref. Further, if the Company is successful in
acquiring new assets or investments, it is likely that the allottees under the 10% Placement Facility
will be the vendors of the new assets or investments, or the nominee of such vendors.
g)
h)
Xref previously obtained Shareholder approval under ASX Listing Rule 7.1A at its 28 November 2018
AGM, and issued no Shares under that approval.
The total number of Equity Securities issued in the 12 months preceding the date of this Meeting
is 7,591,779, made up of 3,876,115 fully paid ordinary shares and 3,715,664 Options. The issue of
Shares represents approximately 2.6% of the total fully paid ordinary shares and 2.2% of the fully
diluted Equity Securities on issue at the commencement of the 12-month period prior to the date
of this Notice of AGM. Details of these issues are:
Ordinary Shares
On 31 January 2019 the Company issued 1,992,673 fully paid ordinary shares on the exercise of
1,992,673 options with an exercise price of $0.23. The closing share price on that date was $0.47.
The names of the entities to whom the Company issued the shares on the exercise of the options
were issued were Taycol Nominees Pty Ltd (842,673shares), Mr Timothy Lloyd Mahony and Jackie
Tadranka Pervan <Mahony Super Fund A/C> (900,000 shares) and Jimbzal Pty Ltd <Taylor Family A/C>
(250,000 shares). The $458,315 raised from the exercise of the options was used for ongoing
operations including local product sales activities and research and development of new products and
to support Xref’s international expansion, which includes its ongoing focus on strategic integrations
and partnerships, and help to drive the key business metrics of client acquisition and client adoption.
On 9 August 2019 the Company issued 1,583,442 fully paid ordinary shares to the two vendors of
Rapid ID Pty Ltd (RapidID) in consideration for the purchase of Rapid ID and its related technology.
These shares were issued at a price of $0.568 per share, being a total amount of $899,395. The
closing share price 9 August 2019 was $0.46, and the acquisition at $0.568 represents a 23% premium
to the share price on that date. The names of the entities to whom the Company issued the shares
issued were Hoedog Enterprises Pty Ltd <Hoey Trust a/c> (829,422shares) and Mr Mark William Hoey
(829,422 754,020 shares). RapidID is a disruptive ID verification and fraud prevention platform, which
aggregates leading customer verification technologies to offer flexible and seamless integration for
onboarding and risk analysis monitoring. RapidID’s platform simplifies identification, screening and
compliance in an all-in-one, integrated API which enables real-time identity verification.
On 9 August 2019 the Company issued 300,000 fully paid ordinary shares to RapidID’s founder, Ashley
Hoey, as a sign-on payment in accordance with his employment contract, covering his role as General
Manager of the now wholly-owned subsidiary, RapidID. These shares were issued at a price of $0.46
per share, being a total amount of $138,000.
Options
On 5 December 2018 the Company issued 3,715,664 options under its EOP to eligible parties. All of
these options were issued for no cash consideration. A total of 315,664 options was issued to 24 of
Xref’s employees and two contractors, and have an exercise price of $0.66 and will expire if not
exercised by 1 August 2022. A total of 2,500,000 options was issued to five of the Company’s senior
employees, and have an exercise price of $0.70 and will expire if not exercised by
29 November 2022. A total of 900,000 options was issued to Xref’s Chief Operating Officer, and
have an exercise price of $0.70 and will expire if not exercised by 3 September 2023.
A Voting Exclusion Statement for this Resolution is included in this Notice of AGM. At the date of this
Notice of AGM, the Company had not approached any particular existing Shareholder or security holder,
or an identifiable class of existing security holder, to participate in the issue of the Equity Securities.
No existing Shareholders’ votes will therefore be excluded under the Voting Exclusion Statement in this
Notice of AGM.
9
Directors’ Recommendation
The Directors recommend that Shareholders vote in favour of Resolution 4. The Chair of the Meeting
intends to vote any undirected proxies in favour of Resolution 4.
5.
RESOLUTION 5 – TO RE-INSERT PROPORTIONAL TAKEOVER PROVISIONS IN THE CONSTITUTION
Background
A proportional takeover bid is an off-market bid under which an offer is made for only a proportion of
each shareholder’s securities. The Corporations Act 2001 (Cth) permits a company to include in its
constitution provisions prohibiting the registration of a transfer of securities resulting from a
proportional takeover bid, unless the relevant holders of the securities approve the bid in a meeting. It
is a requirement of the Corporations Act that such provisions in a company’s constitution apply for a
maximum period of three years, unless renewed earlier by special resolution. In
Share your feedback
Discover